Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by PutinKhuylo1on Jun 08, 2019 6:12pm

201 Views

Post# 29809271

RE:RE:RE:Wex, what does this mean?

Thursday afternoon it was a simple case of market makers realizing they could get a sizeable share count at discount prices by hitting all the stop losses down to .52, when no one was watching. Yesterday morning was panic. By the afternoon, the mm's had made a cool 15%. They know this is going up and they know how to play the game. The typical investor, unfortunately, does not.

Bullboard Posts

Corus reports Q1 profit drop in the face of falling revenue